X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PANACEA BIOTECH UNICHEM LAB/
PANACEA BIOTECH
 
P/E (TTM) x 283.6 -6.7 - View Chart
P/BV x 0.7 2.0 32.6% View Chart
Dividend Yield % 2.6 0.0 -  

Financials

 UNICHEM LAB   PANACEA BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
PANACEA BIOTECH
Mar-14
UNICHEM LAB/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs382149 256.9%   
Low Rs23482 284.4%   
Sales per share (Unadj.) Rs116.384.1 138.2%  
Earnings per share (Unadj.) Rs-18.9-18.3 103.4%  
Cash flow per share (Unadj.) Rs-11.7-6.7 175.3%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.083.7 455.2%  
Shares outstanding (eoy) m70.3461.25 114.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.4 193.0%   
Avg P/E ratio x-16.3-6.3 258.1%  
P/CF ratio (eoy) x-26.2-17.2 152.2%  
Price / Book Value ratio x0.81.4 58.6%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6687,074 306.3%   
No. of employees `0002.32.8 82.9%   
Total wages/salary Rs m2,0061,449 138.4%   
Avg. sales/employee Rs Th3,587.81,874.1 191.4%   
Avg. wages/employee Rs Th880.0527.0 167.0%   
Avg. net profit/employee Rs Th-583.7-407.7 143.2%   
INCOME DATA
Net Sales Rs m8,1805,154 158.7%  
Other income Rs m610100 611.3%   
Total revenues Rs m8,7905,254 167.3%   
Gross profit Rs m-1,320-766 172.3%  
Depreciation Rs m505711 71.0%   
Interest Rs m801,503 5.3%   
Profit before tax Rs m-1,295-2,881 45.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-6 38.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m3317 198.9%   
Profit after tax Rs m-1,331-1,121 118.7%  
Gross profit margin %-16.1-14.9 108.5%  
Effective tax rate %-2.6-0.6 442.4%   
Net profit margin %-16.3-21.8 74.8%  
BALANCE SHEET DATA
Current assets Rs m23,3183,810 612.0%   
Current liabilities Rs m4,6358,365 55.4%   
Net working cap to sales %228.4-88.4 -258.4%  
Current ratio x5.00.5 1,104.5%  
Inventory Days Days122156 78.2%  
Debtors Days Days12167 180.7%  
Net fixed assets Rs m8,16314,480 56.4%   
Share capital Rs m14161 229.5%   
"Free" reserves Rs m26,660903 2,952.1%   
Net worth Rs m26,8015,127 522.7%   
Long term debt Rs m35,832 0.1%   
Total assets Rs m31,89019,433 164.1%  
Interest coverage x-15.2-0.9 1,655.3%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.30.3 96.7%   
Return on assets %-3.92.0 -199.7%  
Return on equity %-5.0-21.9 22.7%  
Return on capital %-4.53.6 -124.9%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m4,3561,539 283.0%   
Fx outflow Rs m0942 0.0%   
Net fx Rs m4,356597 729.5%   
CASH FLOW
From Operations Rs m-1,123599 -187.5%  
From Investments Rs m16,487-438 -3,764.9%  
From Financial Activity Rs m-8,811-303 2,911.9%  
Net Cashflow Rs m6,552-141 -4,636.9%  

Share Holding

Indian Promoters % 50.1 74.5 67.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.6 2,516.7%  
FIIs % 3.0 1.3 230.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.6 134.3%  
Shareholders   20,176 10,259 196.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 142 Points Higher; Metal and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a positive note. Gains were largely seen in the metal sector and healthcare sector.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 21, 2019 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - WOCKHARDT LTD. COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS